Switching between Biologics and Biosimilars

Switching between Biologics and Biosimilars

Ahead of the Biosimilars Commercialisation Summit Pharma IQ sat down and spoke with Kalveer Flora, Specialist Pharmacist Rheumatology and Biosimilars, London North West Healthcare NHS Trust to talk about the adoption of biosimilars in the market.


Download this piece to gain insight into:

  • The importance of offering patients guidance when switching between biologics and biosimilars 
  • What concerns inhibit prescribers switching patients to biosimilars
  • How the UK market compares to the rest of the world on stakeholder confidence and acceptance of biosimilars 

Please note: That all fields marked with an asterisk (*) are required.